This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report of Six Cases

C. J. D. ZARAFONETIS, M.D.; A. C. CURTIS, M.D.; A. E. GULICK, M.D.

Arch Intern Med. 1950;85(1):27-43.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE PURPOSE of this report is to present certain preliminary observations on the effects of paraaminobenzoic acid in dermatomyositis and in scleroderma. Neither the cause nor the pathogenesis of these rare conditions is understood. The concept of "diffuse collagen disease," however, is generally accepted as being applicable to them and to lupus erythematosus. Baehr and Pollack¹ have pointed out that this does not necessarily indicate a close relationship between these disorders, and that it cannot be assumed that their pathogeneses are similar. Nevertheless, it appeared logical to anticipate from the results obtained in lupus erythematosus² that paraaminobenzoic acid might also be beneficial in dermatomyositis and in scleroderma.

The rationale for administering large doses of paraaminobenzoic acid to patients with lupus erythematosus has been dealt with elsewhere.^2a,c Briefly, it was recalled that exposure to sunlight may induce a relapse or cause an exacerbation of lupus erythematosus. It was . . . [Full Text PDF of this Article]

Author Affiliations
ANN ARBOR, MICH.

From the Departments of Internal Medicine and of Dermatology and Syphilology, University Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?